SAVA Healthcare
SAVA Healthcare Limited is a leading pharmaceutical company with a focus on respiratory conditions like asthma and COPD, including the development of advanced nasal sprays. With robust manufacturing capabilities and a global regulatory presence, SAVA Healthcare is committed to developing accessible, effective, and high-quality treatments to help patients breathe better and live longer. The company emphasizes innovation, scalable manufacturing, and expanding access to affordable respiratory solutions across various markets.
Industries
Nr. of Employees
large (251-1000)
SAVA Healthcare
SAVA House, Off New Airport Road, Viman Nagar, Pune – 411014 INDIA
Patents
Use of sodium dichloroisocyanurate (NaDCC) and a pharmaceutical formulation prepared therefrom
US-11944632-B2
View Details
Use of sodium dichloroisocyanurate (NaDCC) and a pharmaceutical formulation prepared therefrom
US-11944632-B2
View DetailsProducts
Nasal sprays and drops (product portfolio)
Portfolio of nasal spray and drop formulations aimed at allergic rhinitis, COPD and upper airway inflammation.
Dry powder inhaler (DPI) products
Dry powder inhaler products for delivery of medication to the lungs for asthma, COPD and related conditions.
Oral solids (tablets/capsules)
Manufacture and supply of oral solid dosage forms.
Topical preparations
Manufacture of topical formulations for dermatological and other local therapies.
Nebivolol HCl 5 mg (product example)
Specific marketed oral product listing referenced on the site.
Moxifloxacin 400 mg (product example)
Specific marketed oral product listing referenced on the site.
Nasal sprays and drops (product portfolio)
Portfolio of nasal spray and drop formulations aimed at allergic rhinitis, COPD and upper airway inflammation.
Dry powder inhaler (DPI) products
Dry powder inhaler products for delivery of medication to the lungs for asthma, COPD and related conditions.
Oral solids (tablets/capsules)
Manufacture and supply of oral solid dosage forms.
Topical preparations
Manufacture of topical formulations for dermatological and other local therapies.
Nebivolol HCl 5 mg (product example)
Specific marketed oral product listing referenced on the site.
Moxifloxacin 400 mg (product example)
Specific marketed oral product listing referenced on the site.
Services
Third‑party development and large‑scale manufacture of pharmaceutical formulations for domestic and international customers.
Formulation development, analytical method development and related R&D services performed at a DSIR‑approved R&D center.
Early‑stage discovery activities to identify and progress novel therapeutic candidates via an internal Innovation and Drug Discovery team.
Facilitation of international distribution and market entry leveraging multiple national/regional accreditations and export experience.
Third‑party development and large‑scale manufacture of pharmaceutical formulations for domestic and international customers.
Formulation development, analytical method development and related R&D services performed at a DSIR‑approved R&D center.
Early‑stage discovery activities to identify and progress novel therapeutic candidates via an internal Innovation and Drug Discovery team.
Facilitation of international distribution and market entry leveraging multiple national/regional accreditations and export experience.
Expertise Areas
- Contract development and manufacturing (CDMO/CRAMS)
- Respiratory drug development and nasal drug delivery
- Formulation development and analytical method development
- cGMP manufacturing and production scale-up
Key Technologies
- Nasal drug delivery platforms
- Dry powder inhaler technology
- Inhalation device filling and vial manufacturing
- cGMP pharmaceutical manufacturing
News & Updates
An article discussing the benefits of blister packaging in the pharmaceutical industry.
An article discussing the benefits of blister packaging in the pharmaceutical industry.